Treatment for Central Nervous System (CNS) Lyme Disease
For patients with CNS Lyme disease involving parenchymal brain or spinal cord, intravenous (IV) antibiotics are strongly recommended over oral antibiotics. 1, 2
First-line Treatment Options
- IV ceftriaxone (2g once daily for 14-21 days) is the preferred parenteral regimen for CNS Lyme disease due to its convenient once-daily dosing and excellent CNS penetration 3, 1, 3
- Alternative parenteral options include:
Treatment Based on Neurological Manifestations
Lyme Meningitis, Radiculopathy, or Other PNS Manifestations
- For Lyme disease-associated meningitis, cranial neuropathy, or radiculoneuropathy without parenchymal involvement:
Parenchymal Brain or Spinal Cord Involvement
- For Lyme disease with parenchymal involvement of brain or spinal cord:
Isolated Facial Nerve Palsy
- For patients with isolated facial nerve palsy without other CNS symptoms:
Special Considerations
- Patients with increased intracranial pressure may require additional interventions such as serial lumbar punctures, corticosteroids, or acetazolamide 3
- In rare cases with severe increased intracranial pressure affecting vision, CSF shunting may be necessary 3
- The response to treatment for late neurologic manifestations is typically slow and may be incomplete 4
Important Pitfalls to Avoid
- Avoid using first-generation cephalosporins (e.g., cephalexin), fluoroquinolones, carbapenems, vancomycin, metronidazole, and tinidazole as they are ineffective against B. burgdorferi 4
- Avoid long-term antibiotic therapy, pulsed-dosing, or combination antimicrobials as these approaches lack supporting evidence and may cause harm 4
- Do not use macrolides (e.g., azithromycin, clarithromycin) as first-line agents as they are less effective than other antibiotics 4
- Avoid interpreting persistent positive serology after treatment as evidence of ongoing infection; antibodies may persist for years after successful treatment 4
Monitoring and Follow-up
- Clinical improvement is the most reliable indicator of treatment success, not laboratory testing 4
- Most patients respond promptly to appropriate antibiotic therapy, but approximately 10% may have persistent symptoms 5
- Consider co-infections with Babesia microti or Anaplasma phagocytophilum in patients with persistent symptoms despite appropriate therapy 4
Emerging Evidence
- Recent research suggests that oral doxycycline may be effective even for CNS symptoms of Lyme neuroborreliosis, showing similar decreases in CSF mononuclear cell counts compared to patients with PNS symptoms 6
- However, current guidelines still strongly recommend IV antibiotics for parenchymal CNS involvement 1, 2
By following these evidence-based recommendations, clinicians can effectively treat CNS Lyme disease while minimizing potential complications and unnecessary treatments.